Clinical Trial

The Workplace-Based Hypertension Management Program

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.
Trial Details
NCT Number NCT07265193
Lead Sponsor Guangxi Medical University
Conditions Hypertension
Enrollment 512 participants
Start Date 2026-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-04